Epoch Investment Partners, Inc. Pacira Bio Sciences, Inc. Transaction History

Epoch Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $19.3 Million - $27.9 Million	-701,585 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$29.98 - $46.35 $995,276 - $1.54 Million	33,198 Added 4.97%	701,585 $21.9 Million
Q4 2017 Feb 13, 2018	BUY	$31.85 - $46.95 $4.22 Million - $6.22 Million	132,388 Added 24.7%	668,387 $30.5 Million
Q3 2017 Nov 13, 2017	BUY	$35.7 - $39.5 $19.1 Million - $21.2 Million	535,999	535,999 $20.1 Million

259

49.5M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.14B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Epoch Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Epoch Investment Partners, Inc. with notifications on news.